In NSCLC the prognostic role of FABP3 is not known, while in gastric cancer, high expression of heart-type FABP protein is associated with increased tumoraggressiveness, metastasis and poor prognosis [22]. This evidence concerns the gene FABP3 and non-small cell lung carcinoma.